Article
HSF1-dependent augmentation of aerobic glycolysis by NEK2 fuels lung adenocarcinoma progression
2026-06-17
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> : Lung adenocarcinoma (LUAD), accounting for 50% of non-small cell lung cancer cases, exhibits dismal survival rates due to therapy resistance and metabolic adaptation. While NIMA related kinase 2 (NEK2), a mitotic kinase, is implicated in tumor progression, its mechanistic role in LUAD-associated glycolysis remains elusive. <bold>Materials and Methods:</bold...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6a76a3c2-04d9-5fb6-8294-351a20d78ed3
- DOI
- 10.21203/rs.3.rs-7715304/v1
